Nutriband (NASDAQ:NTRB) Trading 0.7% Higher

Nutriband Inc. (NASDAQ:NTRB) was up 0.7% during trading on Monday . The stock traded as high as $6.12 and last traded at $6.05. Approximately 20,877 shares traded hands during trading, a decline of 44% from the average daily volume of 37,099 shares. The stock had previously closed at $6.01.

Nutriband Price Performance

The stock has a 50-day moving average of $5.59 and a two-hundred day moving average of $5.03. The firm has a market cap of $66.77 million, a price-to-earnings ratio of -7.86 and a beta of 1.08. The company has a current ratio of 6.57, a quick ratio of 6.36 and a debt-to-equity ratio of 0.01.

Nutriband (NASDAQ:NTRB) last announced its earnings results on Tuesday, September 3rd. The company reported ($0.12) EPS for the quarter. The firm had revenue of $0.44 million during the quarter. Nutriband had a negative return on equity of 66.60% and a negative net margin of 401.39%.

Institutional Trading of Nutriband

An institutional investor recently bought a new position in Nutriband stock. Virtu Financial LLC purchased a new stake in shares of Nutriband Inc. (NASDAQ:NTRB) during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 12,862 shares of the company’s stock, valued at approximately $58,000. Virtu Financial LLC owned 0.12% of Nutriband at the end of the most recent quarter. 19.70% of the stock is currently owned by institutional investors and hedge funds.

Nutriband Company Profile

Nutriband Inc develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy.